Impact of TP53 mutations on efficacy of PD-1 targeted immunotherapy in non-small cell lung cancer (NSCLC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891113735
